Cargando…

Potential of Stem Cell-Based Therapy for Ischemic Stroke

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several studies have been devoted to assessing the therapeutic potential of different types of stem cells such as neural stem cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marei, Hany E., Hasan, A., Rizzi, R., Althani, A., Afifi, N., Cenciarelli, C., Caceci, Thomas, Shuaib, Ashfaq
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808289/ https://www.ncbi.nlm.nih.gov/pubmed/29467713 http://dx.doi.org/10.3389/fneur.2018.00034

Ejemplares similares

Current progress in chimeric antigen receptor T cell therapy for glioblastoma multiforme
por: Marei, Hany E., et al.
Publicado: (2021)

p53 signaling in cancer progression and therapy
por: Marei, Hany E., et al.
Publicado: (2021)

Pandemic COVID-19 caused by SARS-CoV-2: genetic structure, vaccination, and therapeutic approaches
por: Marei, Hany E., et al.
Publicado: (2021)

Exome sequencing of glioblastoma-derived cancer stem cells reveals rare clinically relevant frameshift deletion in MLLT1 gene
por: Marei, Hany E., et al.
Publicado: (2022)

Glioma extracellular vesicles for precision medicine: prognostic and theragnostic application
por: Marei, Hany E., et al.
Publicado: (2022)

Genetically unmatched human iPSC and ESC exhibit equivalent gene expression and neuronal differentiation potential
por: Marei, Hany E., et al.
Publicado: (2017)

Editorial: Inflammation in ischemic stroke and novel therapeutic strategies for stroke treatment
por: Marei, Hany E., et al.
Publicado: (2022)

Potential of antibody–drug conjugates (ADCs) for cancer therapy
por: Marei, Hany E., et al.
Publicado: (2022)

Gene Expression Profiling of Embryonic Human Neural Stem Cells and Dopaminergic Neurons from Adult Human Substantia Nigra
por: Marei, Hany E. S., et al.
Publicado: (2011)

Recent Prospective in CAR T-Based Therapy for Solid and Hematological Malignancies
por: Marei, Hany E., et al.
Publicado: (2023)

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired
por: Marei, Hany E., et al.
Publicado: (2023)

Over-Expression of hNGF in Adult Human Olfactory Bulb Neural Stem Cells Promotes Cell Growth and Oligodendrocytic Differentiation
por: Marei, Hany E. S., et al.
Publicado: (2013)

The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets
por: Cenciarelli, Carlo, et al.
Publicado: (2017)

Human Olfactory Bulb Neural Stem Cells (Hu-OBNSCs) Can Be Loaded with Paclitaxel and Used to Inhibit Glioblastoma Cell Growth
por: Marei, Hany E., et al.
Publicado: (2019)

Oxidative Stress, Inflammation, and Autophagy: Potential Targets of Mesenchymal Stem Cells-Based Therapies in Ischemic Stroke
por: He, Jialin, et al.
Publicado: (2021)

Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
por: Sohail, Muhammad U., et al.
Publicado: (2017)

Reperfusion Therapies of Acute Ischemic Stroke: Potentials and Failures
por: Tsivgoulis, Georgios, et al.
Publicado: (2014)

Collateral Circulation in Ischemic Stroke: An Updated Review
por: Maguida, Gino, et al.
Publicado: (2023)

Mesenchymal Stem Cells in the Treatment of Traumatic Brain Injury
por: Hasan, Anwarul, et al.
Publicado: (2017)

Stem Cell-Based Therapy for Experimental Ischemic Stroke: A Preclinical Systematic Review
por: Zhang, Xi-Le, et al.
Publicado: (2021)

Insight Into the Mechanisms and the Challenges on Stem Cell-Based Therapies for Cerebral Ischemic Stroke
por: Liu, Huiyong, et al.
Publicado: (2021)

Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
por: He, Joy Q., et al.
Publicado: (2020)

Potential Therapies for Cerebral Edema After Ischemic Stroke: A Mini Review
por: Yao, Yi, et al.
Publicado: (2021)

Induced Pluripotent Stem Cells for Ischemic Stroke Treatment
por: Duan, Ranran, et al.
Publicado: (2021)

Fate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?
por: Ikegame, Yuka, et al.
Publicado: (2014)

Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer’s disease
por: Marei, Hany E., et al.
Publicado: (2023)

Aspirin inhibits proliferation and promotes differentiation of neuroblastoma cells via p21(Waf1) protein up‐regulation and Rb1 pathway modulation
por: Pozzoli, Giacomo, et al.
Publicado: (2019)

Editorial: Research progress on immune microenvironment and molecular mechanism of glioma
por: Marei, Hany E., et al.
Publicado: (2023)

Editorial: The Ischemic Penumbra: Still the Target for Stroke Therapies?
por: Hillis, Argye E., et al.
Publicado: (2015)

Mechanisms Involved in the Neuroprotection of Electroacupuncture Therapy for Ischemic Stroke
por: Xing, Ying, et al.
Publicado: (2018)

Disruptions of Circadian Rhythms and Thrombolytic Therapy During Ischemic Stroke Intervention
por: Liu, Jennifer A., et al.
Publicado: (2021)

Editorial: Stem cells and progenitor cells in ischemic stroke—fashion or future?
por: Doeppner, Thorsten R., et al.
Publicado: (2015)

Mitochondrial Dynamics: A Potential Therapeutic Target for Ischemic Stroke
por: Zhou, Xiangyue, et al.
Publicado: (2021)

Impaired Collateral Flow in Pial Arterioles of Aged Rats During Ischemic Stroke
por: Ma, Junqiang, et al.
Publicado: (2019)

Gene Expression Profile of Adult Human Olfactory Bulb and Embryonic Neural Stem Cell Suggests Distinct Signaling Pathways and Epigenetic Control
por: Marei, Hany E. S., et al.
Publicado: (2012)

Chinese Ischemic Stroke Subclassification
por: Gao, S., et al.
Publicado: (2011)

Editorial: Remote Ischemic Conditioning (Pre, Per, and Post) as an Emerging Strategy of Neuroprotection in Ischemic Stroke
por: Purroy, Francisco, et al.
Publicado: (2022)

Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke
por: Phan, Thanh G., et al.
Publicado: (2018)

Corrigendum: Revisiting Stem Cell-Based Clinical Trials for Ischemic Stroke
por: He, Joy Q., et al.
Publicado: (2022)

Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke
por: Tajiri, Naoki, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rgran51a6t8053be8pocb7e3g8